News blog

Tristel

• BY: Andrew Hore |
• POSTED: 22/01/2014 |

Infection control products supplier Tristel says that trading in the six months to December 2013 was stronger than expected. 

Tristel is on course to report a rise in revenues from £4.4m to more than £6.4m and a return to profit. The interim profit should be more than £700,000. Net cash was £1.4m at the end of 2013.

The share price rose 5.75p to 51p

The interim figures will be published on 3 March.

Download the latest AIM Journal from http://wwww.hubinvest.com/AIMPDFJanuary2014_52.pdf